SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-22-007545
Filing Date
2022-07-07
Accepted
2022-07-07 17:33:18
Documents
1
Period of Report
2022-07-06

Document Format Files

Seq Description Document Type Size
1 form4-07072022_020709.html 4  
1 form4-07072022_020709.xml 4 4142
  Complete submission text file 0001415889-22-007545.txt   5641
Mailing Address 505 EAGLEVIEW BOULEVARD SUITE 212 EXTON PA 19341
Business Address 505 EAGLEVIEW BOULEVARD SUITE 212 EXTON PA 19341 4843481600
IDERA PHARMACEUTICALS, INC. (Issuer) CIK: 0000861838 (see all company filings)

IRS No.: 043072298 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O IDERA PHARMACEUTICALS, INC. 505 EAGLEVIEW BLVD., SUITE 212 EXTON PA 19341
Business Address
Lim Bryant David (Reporting) CIK: 0001752888 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-31918 | Film No.: 221072403